| Entry |
|
|---|
| Name |
Rimiterol hydrobromide (USAN) |
|---|
| Formula |
C12H17NO3. HBr
|
|---|
| Exact mass |
303.0470
|
|---|
| Mol weight |
304.18
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
DG01951 Catecholamine adrenergic receptor agonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Bronchodilator, beta2-Adrenergic receptor agonist |
|---|
| Comment |
Catecholamine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03A ADRENERGICS, INHALANTS
R03AC Selective beta-2-adrenoreceptor agonists
R03AC05 Rimiterol
D05730 Rimiterol hydrobromide (USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
D05730 Rimiterol hydrobromide
DG01951 Catecholamine adrenergic receptor agonist
D05730 Rimiterol hydrobromide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB2
D05730 Rimiterol hydrobromide (USAN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 17
1 C8y C 14.3500 -16.1700
2 C8y C 14.3500 -14.7700
3 C8x C 15.5400 -14.0700
4 C8x C 16.7300 -14.7700
5 C8y C 16.7300 -16.1700
6 C8x C 15.5400 -16.8700
7 O1a O 13.0900 -14.0700
8 O1a O 13.0900 -16.8700
9 C1c C 17.9900 -16.8700
10 C1y C 19.1800 -16.2400
11 O1a O 17.9900 -18.2700
12 C1x C 19.1800 -14.7700
13 C1x C 20.3700 -14.0700
14 C1x C 21.6300 -14.7700
15 C1x C 21.6300 -16.2400
16 N1x N 20.3700 -16.9400
17 X Br 24.1500 -17.0100
BOND 17
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 1 8 1
9 5 9 1
10 9 10 1
11 9 11 1 #Up
12 10 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 10 16 1
|
|---|